Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$655K Sell
9,431
-1,049
-10% -$80.8K 0.01% 804
2025
Q4
$806K Sell
10,480
-242
-2% -$19.4K 0.01% 695
2025
Q3
$924K Buy
10,722
+1,480
+16% +$112K 0.01% 633
2025
Q2
$631K Sell
9,242
-1,971
-18% -$122K 0.01% 772
2025
Q1
$667K Buy
11,213
+3,227
+40% +$205K 0.01% 703
2024
Q4
$482K Sell
7,986
-4,151
-34% -$254K 0.01% 925
2024
Q3
$856K Buy
12,137
+10
+0.1% +$698 0.01% 633
2024
Q2
$831K Buy
12,127
+4,163
+52% +$320K 0.01% 590
2024
Q1
$634K Buy
7,964
+285
+4% +$23K 0.02% 380
2023
Q4
$689K Buy
+7,679
New +$661K 0.02% 327

Other funds holding APTV

Choreo LLC's APTV Position: Q1 2026 in Review

Choreo LLC reduced its Aptiv (APTV) stake by 10% in Q1 2026, selling an estimated $80.8K and leaving 9,431 shares worth $655K. The position accounts for 0.01% of the portfolio, ranked #804.

Choreo LLC first reported a position in APTV in Q4 2023 and has held it in 10 quarters since. The position peaked at $924K in Q3 2025. 705 funds tracked by Wall St. Rank hold APTV as of Q1 2026.

  • Choreo LLC held 9,431 shares of Aptiv worth $655K as of Q1 2026.
  • Choreo LLC sold 1,049 Aptiv shares in Q1 2026, an estimated $80.8K.
  • Aptiv made up 0.01% of Choreo LLC's portfolio in Q1 2026, its #804 holding.
  • Choreo LLC first reported a position in Aptiv in Q4 2023 and has held it in 10 quarters since.
  • Choreo LLC's Aptiv position peaked at $924K in Q3 2025.
  • 705 funds tracked by Wall St. Rank held Aptiv as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.